Industrie De Nora stock
DNR.MIMILIndustrie De Nora S.p.A., Basic MaterialsISIN IT0005186371
45Score 45 out of 100, Weak
Price and trend
43 / 100
Price history
−20% in one yearThe chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 8.8% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 73).
The price is 26% below its 52-week high. Largest decline in 4 years: 75% (July 2023 to October 2026).
Chart figures for advanced users
- SMA 50$6.61
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$7.15
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)73
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$5.88
- The lowest closing price of the last twelve months.
- Resistance$8.79
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Industrie De Nora S.p.A. belongs to the Chemicals (Specialty) industry (Italy) and, with a market value of $1.32B, is number 88 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $969.54M (up 1.4% year on year) and earnings of $91.24M (down 1.2%).
- For fiscal 2026, analysts expect on average revenue of $998.13M (up 2.9%) and adjusted earnings per share of $0.38 (down 53.7%).
Show more
- MEQIRI Score 45 out of 100 (Weak): rank 359 of 461 in Basic Materials, median 57.
- Our model puts fair value at $1.87, with the price 249% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Consistently profitableProfit in all 8 fiscal years from 2018 to 2025.Fundamentals 54
- Earnings per share growingUp 16.6% a year since 2020.Growth 56
- Growing faster than its industryRevenue up 11.9% a year since 2020, Chemicals (Specialty) median 6%.Growth 56
Weaknesses
- Above fair valuePrice 249% above the fair value of $1.87.Valuation 10
- Negative free cash flowFree cash flow −$55.74M over the last 12 months.Fundamentals 54
- DilutionShare count up 13% since 2020.Capital allocation 26
Its standout strength is stability, while capital allocation and valuation hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 44 to 45.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $1.33 and expensive above $3.11 (uncertainty high, based on the price swings of the past year).
Calculated with a cost of equity of 9.6%. At 10.6% the fair value would be $1.56, at 8.6% it would be $2.30.
Valuation metrics
From the cash-flow model alone; the profit includes one-off items, so there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 2.4% on the twelve months before. Revenue has grown solidly since 2018, at about 9% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 29%, operating 13%, net 9%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 24 Mar 2027in 131 days
- Last reported
- 4 Nov 2026EPS reported $0.15 (expected $0.11)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $0.38−2.0%
- Revenue
- $998.13M0.0%
- Earnings per share
- $0.50+1.2%
- Revenue
- $1.11B−0.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Industrie De Nora
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 45
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- VERBIO Vereinigte BioEnergieVBK.DE $1.81B52
- CorbionCRBN.AS $1.7B66
- BorregaardBRG.OL $1.64B63
- Stepan CoSCL $1.51B51
- ElkemELK.OL $1.22B50
- EcovystECVT $1.17B48
- Oil-Dri Corporation of AmericaODC $981.23M74
- Kronos WorldwideKRO $967.97M51
ETFs that hold Industrie De Nora
Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Hydrogen Economy UCITS ETF USDHTMW | 0.81% | 0.49% | €394.58M |
| L&G Clean Water UCITS ETFXMLC | 0.34% | 0.49% | €588.71M |
| Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DISTLGWU | 0.17% | 0.40% | €580.62M |
Show 5 more
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.06% | 0.23% | €321.86M |
| UBS MSCI EMU Small Cap UCITS ETF EUR disUEFD | 0.04% | 0.28% | €630.46M |
| WisdomTree Europe SmallCap Dividend UCITS ETF AccWTD7 | 0.03% | 0.38% | €86.74M |
| State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR AccZPRX | 0.01% | 0.30% | €813.64M |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.01% | 0.30% | €3.45B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Overvalued since 10 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.